Catalyst Pharmaceuticals (FRA:CN2) Other Income (Expense) : €7.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Catalyst Pharmaceuticals Other Income (Expense)?

Catalyst Pharmaceuticals's other income expense for the Catalyst Pharmaceuticals's pretax income for the three months ended in Mar. 2024 was €1.8 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was €7.3 Mil.

Catalyst Pharmaceuticals Other Income (Expense) Historical Data

The historical data trend for Catalyst Pharmaceuticals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalyst Pharmaceuticals Other Income (Expense) Chart

Catalyst Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

1.43

0.48

0.25

2.72

7.06

Catalyst Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															1.59	1.67	-0.78	4.60	1.81

Catalyst Pharmaceuticals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €7.3 Mil.

Catalyst Pharmaceuticals (FRA:CN2) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Catalyst Pharmaceuticals (FRA:CN2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Catalyst Pharmaceuticals Inc (FRA:CN2) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

CPRX:USA

Address

355 Alhambra Circle, Suite 801, Coral Gables, FL, USA, 33134

Website

https://www.catalystpharma.com

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Catalyst Pharmaceuticals (FRA:CN2) Headlines

No Headlines